CPMV Display of SARS-CoV-2 Epitopes

Highly modular plug-and-play bionanotechnology
  • Highly adaptable system: should mutants or new strains emerge, the peptides can be updated.

  • Precisely controlled and targeted immune response tailored to the epitope of interest.

  • Cocktails incorporating multiple immunogenic domains can be produced.

  • Possible risk of ADE (antibody-dependent enhancement) or Th2 immunopathology may be avoided through rational design and choice of peptide targets.

MI-V-101

MI-V-101 is a chimeric plant virus nanoparticle displaying SARS-CoV-2 peptide epitopes manufactured as a microneedle patch.

  • These microneedle vaccine patches can be self-administered. 
  • The integrated slow-release provides boosts to the immune system providing an effective immunity shield after a single administration.

© 2020 by Mosaic ImmunoEngineering Inc.